Price W. Wilson


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.


Working across a variety of industries, including the healthcare, financial, and food and beverage industries, Price Wilson represents both targets and acquirers in connection with merger and acquisition activity and issuers in connection with debt and equity offerings. Price’s practice has encompassed deals worth nearly $8 billion to financing transactions valued at more than $800 million in aggregate.

Price’s practice involves:

  • Corporate governance
  • Sarbanes-Oxley Act compliance
  • Public company disclosure
  • Section 16 issues and current reporting
  • Mergers and acquisitions
  • Joint ventures
  • Public debt and equity offerings
  • Private placements of securities.

Price’s experience also includes representing U.S. and foreign clients engaged in cross-border transactions.


American Health Law Association (AHLA)